CiVi Biopharma A/S — Credit Rating and Financial Key Figures
CVR number: 38027794
Sundkrogsgade 21, 2100 København Ø
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 7 236.69 | 4 484.62 | 4 035.57 | 3 530.11 | 3 502.14 |
| Employee benefit expenses | -6 393.99 | -3 969.54 | -3 582.80 | -3 099.95 | -3 100.37 |
| EBIT | 842.70 | 515.08 | 452.77 | 430.16 | 401.77 |
| Other financial income | 1.01 | ||||
| Other financial expenses | -9.89 | -11.95 | -10.93 | -10.78 | -3.19 |
| Reduction non-current investment assets | -2 196.94 | ||||
| Pre-tax profit | 833.81 | 503.14 | 441.84 | 419.38 | -1 798.36 |
| Income taxes | - 185.09 | - 111.17 | -97.83 | -93.06 | -88.97 |
| Net earnings | 648.73 | 391.97 | 344.00 | 326.32 | -1 887.33 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Other receivables | 18.33 | ||||
| Investments total | 18.33 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 3 091.13 | 1 448.41 | 1 725.29 | 3 488.24 | 1 750.00 |
| Prepayments and accrued income | 40.08 | 80.55 | 82.88 | 100.51 | 79.56 |
| Current other receivables | 73.22 | 103.97 | 154.50 | 109.88 | 109.59 |
| Current deferred tax assets | 9.83 | 87.17 | 16.52 | ||
| Short term receivables total | 3 204.43 | 1 642.77 | 2 049.83 | 3 698.63 | 1 955.67 |
| Cash and bank deposits | 1 375.82 | 2 471.54 | 2 282.32 | 248.91 | 329.45 |
| Cash and cash equivalents | 1 375.82 | 2 471.54 | 2 282.32 | 248.91 | 329.45 |
| Balance sheet total (assets) | 4 598.58 | 4 114.31 | 4 332.15 | 3 947.54 | 2 285.13 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Retained earnings | 1 164.33 | 1 813.06 | 2 205.03 | 2 549.03 | 2 875.35 |
| Profit of the financial year | 648.73 | 391.97 | 344.00 | 326.32 | -1 887.33 |
| Shareholders equity total | 2 313.06 | 2 705.03 | 3 049.03 | 3 375.35 | 1 488.02 |
| Non-current liabilities total | |||||
| Current trade creditors | 112.32 | 3.62 | 133.71 | 302.52 | 483.22 |
| Short-term deferred tax liabilities | 42.09 | 11.06 | 40.21 | ||
| Other non-interest bearing current liabilities | 2 131.11 | 1 405.66 | 1 149.40 | 258.61 | 273.68 |
| Current liabilities total | 2 285.52 | 1 409.28 | 1 283.11 | 572.19 | 797.11 |
| Balance sheet total (liabilities) | 4 598.58 | 4 114.31 | 4 332.15 | 3 947.54 | 2 285.13 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.